These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 898833)

  • 1. 'How frequent is posttranfusion hepatitis after the introduction of 3rd generation donor screening for hepatitis B? What is its probable nature?
    Vox Sang; 1977; 32(6):346-63. PubMed ID: 898833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy control of HB blood donor screening.
    Fiedler H
    Haematologia (Budap); 1983; 16(1-4):99-104. PubMed ID: 6679491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical problem of hepatitis transmission;
    Barker LF; Gerety RJ
    Prog Clin Biol Res; 1976; 11():163-82. PubMed ID: 799307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B antigen - post transfusion studies in Papua New Guinea.
    Woodfield DG
    Trop Geogr Med; 1977 Sep; 29(3):257-65. PubMed ID: 595131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transfusion hepatitis. Sudden drop of its incidence associated with hyperbilirubinemic donors disqualification.
    Pintera J; Krácmar C; Pinterová A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):415-25. PubMed ID: 2428716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis after the transfusion of frozen red cells and washed red cells.
    Haugen RK
    N Engl J Med; 1979 Aug; 301(8):393-5. PubMed ID: 460339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period.
    Wendel S; Levi JE; Biagini S; Candotti D; Allain JP
    Transfusion; 2008 Aug; 48(8):1602-8. PubMed ID: 18466175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B--significance for transfusion medicine].
    Jilg W
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():20-6. PubMed ID: 8000250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the prevention of post-transfusion hepatitis.
    Mintz PD
    Ann Clin Lab Sci; 1984; 14(3):198-207. PubMed ID: 6428295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of HBV genome by gene amplification method in HBsAg negative blood donors.
    Bodhiphala P; Chaturachumroenchai S; Chiewsilp P; Pruksananonda P
    J Med Assoc Thai; 1999 May; 82(5):491-5. PubMed ID: 10443099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National blood requirement, serum ALT and hepatitis in Ethiopian blood donors.
    Zawde D; Sisay Y
    Ethiop Med J; 1991 Oct; 29(4):175-83. PubMed ID: 1659534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV--status in professional blood donors in north India.
    Irshad M; Singh YN; Acharya SK
    Trop Gastroenterol; 1992; 13(3):112-4. PubMed ID: 1488797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple strategy to look back on posttransfusion hepatitis B in a multitransfused patient.
    Jongerius JM; van der Poel CL; van Leeuwen EF
    Vox Sang; 1998; 75(1):66-9. PubMed ID: 9745157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
    Weber B; Mühlbacher A; Melchior W
    J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.